Rachel A. Burga

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases

Steven C. Katz, Rachel A. Burga, Elise McCormack et al. · Clinical Cancer Research · 2015 · 379 citations

Medicine, Immunology, Oncology +17

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T

Rachel A. Burga, Mitchell Thorn, Gary R. Point et al. · Cancer Immunology Immunotherapy · 2015 · 224 citations · Full text

Medicine, Cancer Biology, Oncology +16

A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration

Nora T. Khanarian, Nora M. Haney, Rachel A. Burga et al. · Biomaterials · 2012 · 154 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +14

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma

Juliana Cano‐Mejia, Rachel A. Burga, Elizabeth E. Sweeney et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 148 citations · Full text

Medicine, Cancer Biology, Oncology +16

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma

Eric Yvon, Rachel A. Burga, Allison B. Powell et al. · Cytotherapy · 2017 · 132 citations

Medicine, Immunology, Oncology +16